We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Summit Therapeutics Plc | LSE:SUMM | London | Ordinary Share | GB00BN40HZ01 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 20.50 | 18.00 | 23.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMSUMM BLOCK LISTING SIX MONTHLY RETURN (Note: Italicised terms have the same meaning as given in the Listing Rules.) Date: 29 April 2019 Name of applicant: Summit Therapeutics plc -------------------------------------------------------------- ----------------------------- Name of scheme: 2005 EMI Scheme -------------------------------------------------------------- ----------------------------- Period of return: From: 30 Sep 2018 To: 31 Mar 2019 -------------------------------------- ---------------------- ----------- --- ----------- Balance of unallotted securities under scheme(s) from previous return: 4,402,293 -------------------------------------------------------------- ----------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): Zero -------------------------------------------------------------- ----------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): Zero -------------------------------------------------------------- ----------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 776,756 -------------------------------------------------------------- ----------------------------- Name of applicant: Summit Therapeutics plc -------------------------------------------------------------- -------------------------------- Name of scheme: 2016 Long Term Incentive Plan -------------------------------------------------------------- -------------------------------- Period of return: From: 30 Sep 2018 To: 31 Mar 2019 ------------------------------------ ------------------------ ------------ ---- ------------ Balance of unallotted securities under scheme(s) from previous return: 4,196,863 -------------------------------------------------------------- -------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): Zero -------------------------------------------------------------- -------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): Zero -------------------------------------------------------------- -------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 4,196,863 -------------------------------------------------------------- -------------------------------- Name of contact: Richard Pye ----------------------------- ------------------ Telephone number of contact: +44 (0)1235 443951 ----------------------------- ------------------ This figure has been reduced since the last block list review to reflect the number of share options that remain in existence under the 2005 EMI Scheme. This change is due to the voluntary surrender of share options, as announced by regulatory information service on 8 October 2018, that included options awarded under the 2005 EMI Scheme. Other share options issued under the 2005 EMI Scheme lapsed due to employees leaving the Company and these changes are also reflected in the reduced figure. No new share options will be issued under the 2005 EMI Scheme.
(END) Dow Jones Newswires
April 29, 2019 07:30 ET (11:30 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Summit Therapeutics Chart |
1 Month Summit Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
